# TraceLink

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tracelink

- Industry: Software
- Headquarters: US
- Website: www.tracelink.com
- Total disclosed funding: $225M
- Latest round: Series D (Aug 21, 2018)
- Investors on record: 7

## About

TraceLink Inc. offers comprehensive supply chain orchestration solutions, enhancing visibility and efficiency for stakeholders within the healthcare and life sciences industries.Founded in 2009 in the United States, TraceLink Inc. specializes in supply chain solutions for the healthcare sector. The company has completed a total of 7 deals, with its most recent funding round occurring on August 21, 2018. This Series D round raised USD 93.00 mn, led by Georgian Partners, with participation from F-Prime Capital, FirstMark Capital, Goldman Sachs Merchant Banking Division, Volition Capital, Vulcan Capital, and Willett Advisors. The firm was established with the vision of improving supply chain efficiency in healthcare, and its CEO is Shabbir Dahod, while the founder is Bhansali Rajkumar.TraceLink specializes in end-to-end supply chain orchestration, providing a robust suite of solutions designed to enhance visibility and efficiency across the healthcare and life sciences sectors. Their core products include the Multienterprise Information Network Tower (MINT) and the OPUS platform, which facilitate integration and real-time data exchange among supply chain partners. MINT is recognized for its scalability and compliance capabilities, helping organizations meet regulatory demands such as the U.S. Drug Supply Chain Security Act (DSCSA). TraceLink serves a diverse client base, including life sciences companies, healthcare providers, wholesale distributors, and third-party logistics providers across global markets, including North America, Europe, and Asia. The company's solutions address issues such as drug shortages and compliance exceptions, aiming to improve operational resilience.TraceLink operates on a subscription-based revenue model, allowing clients to access a suite of digital supply chain solutions. The company engages in B2B transactions with stakeholders in the healthcare ecosystem, including manufacturers, distributors, and pharmacies. Clients pay for services based on the specific solutions they implement, such as the MINT platform or OPUS for real-time visibility. The structured pricing plan accommodates the diverse needs of clients without additional fees for continuous compliance updates.TraceLink plans to leverage its recent Series D funding of USD 93.00 mn to support the development of new products and enhance its presence in the healthcare supply chain sector. The company aims to expand its operations into emerging markets in Asia and Europe by the end of 2023. The funding will enable TraceLink to innovate its existing platforms and potentially introduce new features that address the evolving demands of the industry.

## Funding rounds

- Series D, Aug 21, 2018, $93M — F-Prime Capital, FirstMark Capital, Georgian, Volition Capital, Willett Advisors, Goldman Sachs Asset Management, Vulcan Capital
- Series D, May 25, 2018, $60M — F-Prime Capital, FirstMark Capital, Volition Capital, Goldman Sachs Asset Management
- Series C, Nov 18, 2016, $52M — F-Prime Capital, FirstMark Capital, Volition Capital, Goldman Sachs Asset Management
- Series B, Feb 13, 2015, $20M — F-Prime Capital, FirstMark Capital, Volition Capital

## Investors

- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series B, Series C, Series D
- FirstMark Capital (https://capitalatlas.ai/funds/firstmark-capital) — Series B, Series C, Series D
- Volition Capital (https://capitalatlas.ai/funds/volition-capital) — Series B, Series C, Series D
- Goldman Sachs Asset Management (https://capitalatlas.ai/funds/goldman-sachs-asset-management) — Series C, Series D
- Georgian — Series D
- Willett Advisors — Series D
- Vulcan Capital (https://capitalatlas.ai/funds/vulcan-capital) — Series D